Associate Professor Jake Shortt is a Consultant Haematologist at Monash Health, and the Head of Haematology Research at Monash University School of Clinical Sciences. He is the clinical lead at Monash for leukaemia and myelodysplasia. He is a Principal Investigator on both industry-sponsored and academic (investigator initiated) clinical trialsresearch studies performed to test new treatments, tests or procedures and evaluate their effectiveness on various diseases in leukaemia, myelodysplasia, lymphoma and myeloma. He is on the steering committee of the Australasian Lymphoma and Related Diseases Registry, the Scientific Advisory Committee of the Australasian Leukaemia and Lymphoma Group (ALLG) and chairs the ALLG Laboratory Sciences Committee. His research in the ‘Blood Cancer Therapeutics Laboratory’ in the Monash Health Translation Precinct is focused on developing new treatments for myeloma and lymphoma. Associate Professor Shortt’s research is supported by grants from the NHMRC, Victorian Cancer Agency, Snowdome Foundation and Cancer Council of Victoria.
Location
246 Clayton Rd, Clayton VIC, Australia
